4,501–4,550 of 20,598 genesranked by Most Researched
| # | Gene | Name | Chr | Tags | PubMed Papers |
|---|---|---|---|---|---|
| 4501 | SAP30BP | SAP30 binding protein | 17 | Experimental GO EvidenceSwiss-Prot Reviewed | 106 |
| 4502 | SS18 | SS18 subunit of BAF chromatin remodeling complex | 18 | OncogeneExperimental GO Evidence | 106 |
| 4503 | STX6 | syntaxin 6 | 1 | Hub GeneTransporter | 106 |
| 4504 | TDP1 | tyrosyl-DNA phosphodiesterase 1 | 14 | DNA RepairOMIM Disease Gene | 106 |
| 4505 | TINF2 | TERF1 interacting nuclear factor 2 | 14 | OMIM Disease GeneExperimental GO Evidence | 106 |
| 4506 | VPS13A | vacuolar protein sorting 13 homolog A | 9 | TransporterOMIM Disease Gene | 106 |
| 4507 | WDHD1 | WD repeat and HMG-box DNA binding protein 1 | 14 | DNA RepairHub Gene | 106 |
| 4508 | ACSL1 | acyl-CoA synthetase long chain family member 1 | 4 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4509 | ADH5 | alcohol dehydrogenase 5 (class III), chi polypeptide | 4 | Clinical TrialsOMIM Disease Gene | 105 |
| 4510 | ADRA2C | adrenoceptor alpha 2C | 4 | ReceptorFDA Approved Target | 105 |
| 4511 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | 6 | FDA Approved TargetOMIM Disease Gene | 105 |
| 4512 | ANKRD28 | ankyrin repeat domain 28 | 3 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4513 | ATP5IF1 | ATP synthase inhibitory factor subunit 1 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4514 | BHMT | betaine--homocysteine S-methyltransferase | 5 | FDA Approved TargetExperimental GO Evidence | 105 |
| 4515 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | Highly ConstrainedExperimental GO Evidence | 105 |
| 4516 | CCNB2 | cyclin B2 | 15 | Hub GeneExperimental GO Evidence | 105 |
| 4517 | CENPB | centromere protein B | 20 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4518 | COPS7A | COP9 signalosome subunit 7A | 12 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4519 | DOK1 | docking protein 1 | 2 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4520 | DUT | deoxyuridine triphosphatase | 15 | OMIM Disease GeneExperimental GO Evidence | 105 |
| 4521 | E2F7 | E2F transcription factor 7 | 12 | Transcription FactorClinical Trials | 105 |
| 4522 | EFNA1 | ephrin A1 | 1 | Tumor SuppressorExperimental GO Evidence | 105 |
| 4523 | FBXO5 | F-box protein 5 | 6 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4524 | FKBP10 | FKBP prolyl isomerase 10 | 17 | OMIM Disease GeneVariant-Rich | 105 |
| 4525 | GUCY2D | guanylate cyclase 2D, retinal | 17 | Hub GeneOMIM Disease Gene | 105 |
| 4526 | HERC5 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 | 4 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4527 | HOXA13 | homeobox A13 | 7 | OMIM Disease GeneExperimental GO Evidence | 105 |
| 4528 | HOXB9 | homeobox B9 | 17 | Transcription FactorExperimental GO Evidence | 105 |
| 4529 | HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 1 | Hub GeneFDA Approved Target | 105 |
| 4530 | IL12RB2 | interleukin 12 receptor subunit beta 2 | 1 | ReceptorExperimental GO Evidence | 105 |
| 4531 | INO80 | INO80 complex ATPase subunit | 15 | DNA RepairHighly Constrained | 105 |
| 4532 | IRF9 | interferon regulatory factor 9 | 14 | Hub GeneOMIM Disease Gene | 105 |
| 4533 | IST1 | IST1 factor associated with ESCRT-III | 16 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4534 | KDM3B | lysine demethylase 3B | 5 | Highly ConstrainedOMIM Disease Gene | 105 |
| 4535 | KRT13 | keratin 13 | 17 | OMIM Disease GeneExperimental GO Evidence | 105 |
| 4536 | LEO1 | LEO1 component of Paf1/RNA polymerase II complex | 15 | Hub GeneExperimental GO Evidence | 105 |
| 4537 | LRRC47 | leucine rich repeat containing 47 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4538 | LRRFIP1 | LRR binding FLII interacting protein 1 | 2 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4539 | LSG1 | large 60S subunit nuclear export GTPase 1 | 3 | Hub GeneTransporter | 105 |
| 4540 | LZTS2 | leucine zipper tumor suppressor 2 | 10 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4541 | MADD | MAP kinase activating death domain | 11 | OMIM Disease GeneExperimental GO Evidence | 105 |
| 4542 | MAP2K5 | mitogen-activated protein kinase kinase 5 | 15 | KinaseExperimental GO Evidence | 105 |
| 4543 | MST1 | macrophage stimulating 1 | 3 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4544 | NCLN | nicalin | 19 | Hub GeneExperimental GO Evidence | 105 |
| 4545 | NDE1 | nudE neurodevelopment protein 1 | 16 | OMIM Disease GeneExperimental GO Evidence | 105 |
| 4546 | NEIL1 | nei like DNA glycosylase 1 | 15 | DNA RepairExperimental GO Evidence | 105 |
| 4547 | NOP16 | NOP16 nucleolar protein | 5 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4548 | NTPCR | nucleoside-triphosphatase, cancer-related | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4549 | NUPR1 | nuclear protein 1, transcriptional regulator | 16 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |
| 4550 | PARVA | parvin alpha | 11 | Experimental GO EvidenceSwiss-Prot Reviewed | 105 |